Insulin lispro Subcutaneous and Phenazopyridine Plus
Determining the interaction of Insulin lispro Subcutaneous and Phenazopyridine Plus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: butabarbital / hyoscyamine / phenazopyridine
Brand name:
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Phenazopyridine Tablets
- Insulin lispro Subcutaneous-Phencyclidine
- Insulin lispro Subcutaneous-Phendiet
- Insulin lispro Subcutaneous-Phendiet-105
- Insulin lispro Subcutaneous-Phendimetrazine
- Insulin lispro Subcutaneous-Phendimetrazine Extended-Release Capsules
- Phenazopyridine Plus-Insulin NPH
- Phenazopyridine Plus-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Phenazopyridine Plus-Insulin NPH (Vials)
- Phenazopyridine Plus-Insulin NPH and Insulin Regular
- Phenazopyridine Plus-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Phenazopyridine Plus-Insulin NPH and Insulin Regular (Vials)